A blood test for Alzheimer’s disease: progress, challenges and recommendations

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)
194 Downloads (Pure)


Ever since the discovery of APOE ɛ4 around 25 years ago, researchers have been excited about the potential of a blood test for Alzheimer’s disease (AD). Since then researchers have looked for genetic, protein, metabolite, and/or gene expression markers of AD and related phenotypes. However, no blood test for AD is yet being used in the clinical setting. We first review the trends and challenges in AD blood biomarker research, before giving our personal recommendations to help researchers overcome these challenges. While some degree of consistency and replication has been seen across independent studies, several high-profile studies have seemingly failed to replicate. Partly due to academic incentives, there is a reluctance in the field to report predictive ability, to publish negative findings, and to independently replicate the work of others. If this can be addressed, then we will know sooner whether a blood test for AD or related phenotypes with clinical utility can be developed.
Original languageEnglish
Pages (from-to) S289-S297
JournalJournal of Alzheimer's disease : JAD
Issue numbers1
Publication statusPublished - 12 Jun 2018


Dive into the research topics of 'A blood test for Alzheimer’s disease: progress, challenges and recommendations'. Together they form a unique fingerprint.

Cite this